China channel feed – Endpoints News

China channel feed

Juno, WuXi JV in China score $100M in fresh funding as it sets stage for first CAR-T approval

5 years ago

Sanofi sharpens focus on bispecifics, and China, with Alphamab deal

5 years ago

Harvard's Charles Lieber indicted for lying to the feds, bringing US researchers' China ties back to the spotlight

5 years ago

Lilly, Incyte-allied Chinese drugmaker Innovent bags Roche as partner in deal that could yield billions

5 years ago

RA Capital, Hillhouse join $310M rush to back Everest's climb to commercial heights in China

5 years ago

Hillhouse recasts spotlight on China's biotech scene with $160M round for Shanghai-based antibody maker

5 years ago

The big money: Poised to make drug R&D history, a China biotech unveils unicorn racing ambitions in a bid to raise $350M-plus on Nasdaq

5 years ago

As tislelizumab gains traction in China, BeiGene pulls the curtain on NSCLC data supporting the PD-1 drug

5 years ago

Two years in, Hong Kong’s biotech experiment has been validated

6 years ago

BCMA rival to bluebird, Bristol Myers files for $100M IPO as the frontrunners stumble in a race to the finish line

6 years ago

What does a post-pandemic IPO filing look like? Hong Kong biotech application offers clues

6 years ago

The biopharma funding engine motors on, as Chinese biotech raises nearly $280M in monster round

6 years ago

Chinese antibody maker, famed for Ebola cocktail, notches $160M as it focuses on cancer, autoimmune drugs

6 years ago

Ploughing through a crowded PD-(L)1 market, BeiGene loads up on promising lung cancer data

6 years ago

Qiming's China-focused $1.1B new fund brings global haul to $5B within 1 week — but the distribution won't be even

6 years ago

Merck-partnered antibody maker readies $300M IPO as HKEX picks up pace

6 years ago

Lilly Asia Ventures co-leads $100M+ round for Chinese biotech and its late-stage lupus drug

6 years ago

Brii Bio gets all hands on deck for Covid-19 antibody hunt, leveraging Chinese partners' work with recovered patients

6 years ago

BeiGene scrambles to find new Abraxane supplier as Chinese inspectors order halt on imports, citing Bristol Myers failure

6 years ago

InnoCare IPO oversubscribed 300x as Hong Kong investors turned to biotech amid runoff

6 years ago

A Japanese flu drug gets upbeat reviews in China for blunting the impact of Covid-19 — and that is bolstering Gilead's case for remdesivir

6 years ago

Bayer fires employee who was spotted breaking quarantine in China

6 years ago

The big C: The dealmakers, dollars and diseases that have transformed the Chinese biopharma market

6 years ago

Is HKEX ready to return to biotech business? InnoCare tests waters with hopes to fetch $257M in IPO

6 years ago

First page Previous page 16 17 181920 21 22 Next page Last page